全文获取类型
收费全文 | 4364155篇 |
免费 | 342500篇 |
国内免费 | 14691篇 |
专业分类
耳鼻咽喉 | 60434篇 |
儿科学 | 139706篇 |
妇产科学 | 114559篇 |
基础医学 | 667744篇 |
口腔科学 | 118335篇 |
临床医学 | 398394篇 |
内科学 | 791963篇 |
皮肤病学 | 107888篇 |
神经病学 | 368837篇 |
特种医学 | 169813篇 |
外国民族医学 | 755篇 |
外科学 | 657345篇 |
综合类 | 121435篇 |
现状与发展 | 24篇 |
一般理论 | 2624篇 |
预防医学 | 361392篇 |
眼科学 | 101099篇 |
药学 | 308182篇 |
28篇 | |
中国医学 | 11946篇 |
肿瘤学 | 218843篇 |
出版年
2021年 | 56163篇 |
2020年 | 35838篇 |
2019年 | 58823篇 |
2018年 | 74435篇 |
2017年 | 57026篇 |
2016年 | 63138篇 |
2015年 | 76113篇 |
2014年 | 110310篇 |
2013年 | 175886篇 |
2012年 | 124731篇 |
2011年 | 129559篇 |
2010年 | 126017篇 |
2009年 | 127695篇 |
2008年 | 115664篇 |
2007年 | 122960篇 |
2006年 | 131795篇 |
2005年 | 125823篇 |
2004年 | 127241篇 |
2003年 | 117421篇 |
2002年 | 106584篇 |
2001年 | 167265篇 |
2000年 | 162305篇 |
1999年 | 148939篇 |
1998年 | 71729篇 |
1997年 | 67656篇 |
1996年 | 65668篇 |
1995年 | 61082篇 |
1994年 | 55017篇 |
1993年 | 51057篇 |
1992年 | 106827篇 |
1991年 | 101583篇 |
1990年 | 97439篇 |
1989年 | 95027篇 |
1988年 | 87344篇 |
1987年 | 85503篇 |
1986年 | 80376篇 |
1985年 | 78569篇 |
1984年 | 65515篇 |
1983年 | 58320篇 |
1982年 | 47249篇 |
1981年 | 43903篇 |
1980年 | 41109篇 |
1979年 | 55231篇 |
1978年 | 44859篇 |
1977年 | 40056篇 |
1976年 | 36936篇 |
1975年 | 36892篇 |
1974年 | 39703篇 |
1973年 | 37845篇 |
1972年 | 35442篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
921.
Marie Warrer Petersen Tine Sylvest Meyhoff Marie Helleberg Maj-Brit Nørregaard Kjær Anders Granholm Carl Johan Steensen Hjortsø Thomas Steen Jensen Morten Hylander Møller Peter Buhl Hjortrup Mik Wetterslev Gitte Kingo Vesterlund Lene Russell Vibeke Lind Jørgensen Klaus Tjelle Thomas Benfield Charlotte Suppli Ulrik Anne Sofie Andreasen Thomas Mohr Morten H. Bestle Lone Musaeus Poulsen Mette Friberg Hitz Thomas Hildebrandt Lene Surland Knudsen Anders Møller Christoffer Grant Sølling Anne Craveiro Brøchner Bodil Steen Rasmussen Henrik Nielsen Steffen Christensen Thomas Strøm Maria Cronhjort Rebecka Rubenson Wahlin Stephan Jakob Luca Cioccari Balasubramanian Venkatesh Naomi Hammond Vivekanand Jha Sheila Nainan Myatra Christian Gluud Theis Lange Anders Perner 《Acta anaesthesiologica Scandinavica》2020,64(9):1365-1375
Introduction
Severe acute respiratory syndrome coronavirus-2 has caused a pandemic of coronavirus disease (COVID-19) with many patients developing hypoxic respiratory failure. Corticosteroids reduce the time on mechanical ventilation, length of stay in the intensive care unit and potentially also mortality in similar patient populations. However, corticosteroids have undesirable effects, including longer time to viral clearance. Clinical equipoise on the use of corticosteroids for COVID-19 exists.Methods
The COVID STEROID trial is an international, randomised, stratified, blinded clinical trial. We will allocate 1000 adult patients with COVID-19 receiving ≥10 L/min of oxygen or on mechanical ventilation to intravenous hydrocortisone 200 mg daily vs placebo (0.9% saline) for 7 days. The primary outcome is days alive without life support (ie mechanical ventilation, circulatory support, and renal replacement therapy) at day 28. Secondary outcomes are serious adverse reactions at day 14; days alive without life support at day 90; days alive and out of hospital at day 90; all-cause mortality at day 28, day 90, and 1 year; and health-related quality of life at 1 year. We will conduct the statistical analyses according to this protocol, including interim analyses for every 250 patients followed for 28 days. The primary outcome will be compared using the Kryger Jensen and Lange test in the intention to treat population and reported as differences in means and medians with 95% confidence intervals.Discussion
The COVID STEROID trial will provide important evidence to guide the use of corticosteroids in COVID-19 and severe hypoxia.922.
923.
924.
Andriy
Derkach Steven C. Moore Simina M. Boca Joshua N. Sampson 《Statistics in medicine》2020,39(18):2423-2436
We consider the scenario where there is an exposure, multiple biologically defined sets of biomarkers, and an outcome. We propose a new two-step procedure that tests if any of the sets of biomarkers mediate the exposure/outcome relationship, while maintaining a prespecified familywise error rate. The first step of the proposed procedure is a screening step that removes all groups that are unlikely to be strongly associated with both the exposure and the outcome. The second step adapts recent advances in postselection inference to test if there are true mediators in each of the remaining candidate sets. We use simulation to show that this simple two-step procedure has higher statistical power to detect true mediating sets when compared with existing procedures. We then use our two-step procedure to identify a set of Lysine-related metabolites that potentially mediate the known relationship between increased body mass index and the increased risk of estrogen-receptor positive breast cancer in postmenopausal women. 相似文献
925.
Toneva Diana H. Nikolova Silviya Y. Tasheva-Terzieva Elena D. Zlatareva Dora K. Lazarov Nikolai E. 《International journal of legal medicine》2022,136(6):1851-1863
International Journal of Legal Medicine - Sex identification is a primary step in forensic analysis of skeletal remains. The accuracy of sex estimation methods greatly depends on the sexual... 相似文献
926.
927.
The state of the mother''s immune system during pregnancy has an important role in fetal development and disruptions in the balance of this system are associated with a range of neurologic, neuropsychiatric and neurodevelopmental disorders. Epidemiological and clinical reports reveal various clues that suggest a possible association between developmental neuropsychiatric disorders and family history of immune system dysfunction. Over the past three decades, analogous increases have been reported in both the incidence of neurodevelopmental disorders and immune-related disorders, particularly allergy and asthma, raising the question of whether allergic asthma and characteristics of various neurodevelopmental disorders share common causal links. We used a mouse model of maternal allergic asthma to test this novel hypothesis that early fetal priming with an allergenic exposure during gestation produces behavioral deficits in offspring. Mothers were primed with an exposure to ovalbumin (OVA) before pregnancy, then exposed to either aerosolized OVA or vehicle during gestation. Both male and female mice born to mothers exposed to aerosolized OVA during gestation exhibited altered developmental trajectories in weight and length, decreased sociability and increased marble-burying behavior. Moreover, offspring of OVA-exposed mothers were observed to have increased serotonin transporter protein levels in the cortex. These data demonstrate that behavioral and neurobiological effects can be elicited following early fetal priming with maternal allergic asthma and provide support that maternal allergic asthma may, in some cases, be a contributing factor to neurodevelopmental disorders. 相似文献
928.
Gregory N. Gan 《Expert opinion on investigational drugs》2016,25(10):1153-1166
Introduction: Cancer treatment is moving away from conventional cytotoxic drugs and towards agents that target specific proteins and mechanisms important to cancer development or survival. The Hedgehog Pathway (HhP) is a signal transduction pathway and its constitutive activation is tumorigenic in basal cell carcinoma (BCC). The HhP enables phenotypic flexibility, and channels tumor-stroma interactions. As a result, it is over-expressed in numerous cancers as well as in the tumor microenvironment and may represent a promising therapeutic target.Areas covered: In this article, we review the rationale for targeting HhP and its role as an oncogenic driver, in tumor epithelial-to-mesenchymal transition (EMT), and in the tumor microenvironment and describe the results of preclinical and clinical studies involving HhP inhibitors.Expert opinion: HhP activation plays an important role in both the tumor microenvironment and tumor EMT which can lead to treatment resistance for a number of different malignancies. In addition to standard use in BCC, several HhP inhibitors are in preclinical, early, and mid-stage clinical development for other solid and hematologic malignancies. 相似文献
929.
930.
J. Rodríguez-Carrio A. Martínez-Zapico I. Cabezas-Rodríguez L. Benavente Á.I. Pérez-Álvarez P. López J.B. Cannata-Andía M. Naves-Díaz A. Suárez 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2019,29(2):135-143